Skip directly to content

CME Programs

Expired Programs

Hepatitis C: Update On Current Treatment And Emerging Strategies

This program is no longer available for CME credit.

This CME activity examines HCV infection and treatment. Data regarding the undertreatment of HCV and current recommendations for therapy will be discussed, including strategies to overcome initial nonresponse.

Comparative Effectiveness Research: Plans, Promises, and Pitfalls

This program is no longer available for CME credit.

From debates on Capitol Hill to questions between patients and physicians, Comparative Effectiveness Research (CER) and its potential impact on the delivery of healthcare has sparked conversations across the country. Discovery Channel CME has assembled a key group of opinion-leaders to discuss both the opportunity and uncertainty associated with CER. The program helps define CER, describes study designs useful for CER, identifies potential benefits and weaknesses of using CER in daily practice, and reviews the recent AHRQ report on insulin and type 2 diabetes.

Atrial Fibrillation: Assessing Risk, Controlling Rhythm

This program is no longer available for CME credit.

Discovery Channel presents an all new Continuing Medical Education program focused on issues related to atrial fibrillation treatment, especially rhythm control. It is estimated that over 2.5 million Americans are affected by this condition, with the incidence expected to increase significantly as the general population ages. Led by a panel of cardiologists, the program will include discussion about untreated and undertreated atrial fibrillation, highlight recent updates to treatment guidelines and explain strategies for patient adherence.

Effective Strategies to Improve Care of Patients with COPD

This program is no longer available for CME credit.

Discovery Channel presents an all new Continuing Medical Education program focused on issues related to COPD. Dr. Shim and Dr. Truwit discuss strategies to improve the care of patients with COPD, to control symptoms, and to minimize further damage.

Narcolepsy: New Strategies for Diagnosis and Treatment

This program is no longer available for CME credit.

50 to 70 million Americans, or 20% of the US population, are estimated to have a chronic sleeping or wakefulness disorder. Sleep disorders result in billions of dollars in direct health and medical costs each year an estimated $150 billion due to absenteeism, workplace accidents, and other lost productivity.

As most sleep-related disorders manifest with nonspecific symptoms such as fatigue, insomnia, or hypersomnia, a visit to the physician will often be the first encounter for the patient to address these problems. However, data demonstrate that most physicians feel unprepared to address, diagnose, and treat sleep disorders.

One of the most underdiagnosed and untreated sleep conditions is narcolepsy. Narcolepsy is a disabling neurological condition characterized by excessive daytime sleepiness (EDS), cataplexy, hypnagogic hallucinations, and sleep paralysis. It is the second leading cause of EDS, after sleep apnea. Approximately one in every two thousand Americans are believed to have narcolepsy, although much fewer have been diagnosed and treated. Many factors are attributed to under diagnosis and misdiagnosis. Physicians need to be better prepared to suspect narcolepsy in patients, differentiate narcolepsy from other sleep disorders or medical conditions with overlapping symptoms, initiate the proper diagnostic tests, and refer to a sleep specialist when appropriate.

When Minutes Matter: Proper Anaphylaxis Treatment

This program is no longer available for CME credit.

A group of key opinion leaders discuss triggers of anaphylaxis and treatment options for children and adults.

Challenges and Solutions In The Care of Serious MRSA Infections

This program is no longer available for CME credit.

MRSA infections have become very common in the U.S. In this CME webinar, Dr. Donald Poretz discusses the diagnosis and challenges of treating MRSA (Methicillin-resistant Staphylococcus Aureus), a type of staph bacteria that is resistant to certain antibiotics.

Individualized Therapy for Non-Small Cell Lung Cancer

This program is no longer available for CME credit.

Non-small cell lung cancer represents about 85% of primary malignant tumors in the lung, yet some barriers still exist which may impede diagnosis and treatment. Discovery Channel CME has assembled a panel of key opinion leaders to discuss emerging and individualized therapies for patients with non-small cell lung cancer. The program addresses topics including appropriate first- line chemotherapeutic regimens, how to manage patients for whom first-line treatment has failed, as well as the role of biomarkers for the selection of targeted therapies. Differences in outcomes among minority patients are also discussed, with an emphasis on strategies to overcome challenges to treatment.

Hormone Therapy Options for Contraception and Menopause

This program is no longer available for CME credit.

Discovery Channel CME has assembled a panel of key opinion leaders to discuss the wide range of hormonal options available to women for contraception and problems related to menopause. The program will examine the appropriate use and safety of hormonal therapies and review emerging hormonal options, as well as more established options. Following the program, physicians, other prescribers, pharmacists and health educators will be better able to address misconceptions about hormonal therapies.

Critical Issues In Managing Pain With Opioid Therapy

This program is no longer available for CME credit.

Chronic non-cancer pain is a common and complex clinical problem. This program will review the evidence that demonstrates the prevalence of chronic pain and its debilitating, costly effects when inadequately treated. Opioid therapy may be an integral part of a patient's treatment plan if the proper precautions and direction are taken prior to its induction. However, there are serious concerns by clinicians related to the development of addiction and other aberrant drug-related behaviors in patients for whom opioid therapy may be necessary. This program is designed to discuss the implementation of a pain management plan that utilizes risk assessment tools and monitoring strategies and provides considerations for the use of abuse-deterrent formulations of opioid therapy.

Pages